The full interview with Shire CEO Flemming Ørnskov at J.P. Morgan Health in San Francisco.
CNBC's Meg Tirrell speaks with Merck CEO Ken Frazier about the impact that tax reform will have on the company and the company's overall performance.
The full interview with MyoKardia CEO Tassos Gianakakos at J.P. Morgan Health in San Francisco.
The full interview with Incyte CEO Hervé Hoppenot at J.P. Morgan Health in San Francisco.
BioMarin CEO Jean-Jacques Bienaime discusses the company's hemophilia A treatment at J.P. Morgan Health in San Francisco.
CNBC's Meg Tirrell speaks with Editas CEO Katrine Bosley about the company's stock reacting to questions raised on Crispr technology efficacy.
CNBC's Meg Tirrell speaks to Celgene CEO Mark Alles about the company's acquisition of Impact Biomedicines and what it could mean for the company.
The full interview with Celgene's Mark Alles at the 2018 J.P. Morgan Health in San Francisco.
Emma Walmsley, GlaxoSmithKlein CEO, speaks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about reshaping the company and her outlook for 2018.
At the J.P. Morgan Health Care Conference, Eli Lilly CEO David Ricks speaks to CNBC's Meg Tirrell about the state of health care this year, drug pricing and the impact of tax reform on the pharmaceutical industry.
CNBC's Deirdre Bosa reports big technology companies are accelerating efforts to remake the health care industry.
In an exclusive CNBC interview Michel Vounatsos, Biogen CEO talks to CNBC's Meg Tirrell at the J.P. Morgan Health Care Conference about investing in health care under President Trump and the impact of tax reform on mergers and acquisition. Also Vounatsos weighs in on Biogen's drug pipeline and drug pricing.
Jim Cramer looked ahead to the stocks and events he'll watch next week, including two major conferences and earnings from the banks.
Jim Cramer looked ahead to the stocks and events he'll watch next week, including two major conferences and earnings from the banks.
Jonathan Bush, Athenahealth chairman, CEO & president, speaks with CNBC's Meg Tirrell at about Obamacare and the potential repeal of the law.